Multimodal Imaging Study on Physical Activity in Patients With Alzheimer's Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Alzheimer Disease
- Sponsor
- RWTH Aachen University
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Structural changes of the brain induced by intervention program
- Last Updated
- 6 years ago
Overview
Brief Summary
This study aims to gain a better understanding of metabolic early changes in neurodegenerative diseases, in order to enable new diagnostic and therapeutic approaches in the future. Further, it aims to identify specific movement-induced changes at the cerebral level, on cognition, on quality of life and physical fitness, and on serology parameters in neurodegenerative diseases.
In general, valid biomarkers are needed for early diagnosis and prediction of disease progression. It has been hypothesized that metabolic changes may precede structural changes and may be examined by intervention with exercise therapy. The non-invasive, in vivo characterization and diagnosis of such metabolic changes is therefore of paramount importance. In this line, this research project is focused on applying magnetic resonance imaging (MRI) based metabolic imaging techniques such as sodium MRI and phosphorus magnetic resonance spectroscopy (MRS) with standard structural and functional MRI methods, combined with exercise training, in order to detect biomarkers early in different stages of neurodegenerative diseases. Moreover, this project aims to examine the sensitivity of metabolic imaging with sodium and phosphorus sequences over classical MRI imaging with whole body fat sequences, in order to detect cerebral alterations.
At the end, the medical benefit of the planned project lies in the fact that the expected findings are groundbreaking for the understanding of the phenomenology and pathobiology of neurodegenerative diseases. This is the basis for the development of new methods for early diagnosis and individualized medicine with the optimization of future treatment options.
Investigators
Eligibility Criteria
Inclusion Criteria
- •prodromal or early symptomatic Alzheimer's disease according to the S3 guidelines of the German Society of Neurology in relation to the IWG-2 criteria for the definition of probable Alzheimer's disease
- •Age between 50 and 80 years
- •Mini Mental State Examination (MMSE)\> 19 (screening at least 12 weeks before baseline visit)
- •Cognitive ability to understand the task as well as regular participation in exercise program, based on assessment of the treating neurologist and / or neuropsychologist
- •For antidementive or antidepressant medication, stable medication for at least 30 days
- •No visual or auditory limitation preventing participation in cognitive and functional testing
- •Interested in regular participation for 6 months, doing domestic exercises
- •Presence of a written informed consent
- •Exclusion criteria:
- •Heart attack or evidence of coronary heart disease (angina) in the last 2 years
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Structural changes of the brain induced by intervention program
Time Frame: T1 (baseline), T3 (6 months, after intervention), T4 (optional, 1 year after intervention)
Standard MR Imaging
Metabolic changes of the brain induced by intervention program
Time Frame: T1 (baseline), T3 (6 months, after intervention), T4 (optional, 1 year after intervention)
Phosphor MR Imaging